par Moretti, Luigi
;Roelandts, Martine
;Van Houtte, Paul
;Berghmans, Thierry 
Référence Cancer radiothérapie, 11, 1-2, page (53-58)
Publication Publié, 2007-01




Référence Cancer radiothérapie, 11, 1-2, page (53-58)
Publication Publié, 2007-01
Article révisé par les pairs
Résumé : | If surgery remains the cornerstone for the curative treatment of non-small cell lung cancer, failures are common especially for stage III disease and adjuvant treatment (chemotherapy or radiotherapy) may be justified. After the two meta-analyses, new trials have showed a moderate but significant benefit from cisplatin based chemotherapy. The role of radiotherapy is still controversial but from some clinical observations, a new trial using the modern radiation technology should address the question. © 2006 Elsevier Masson SAS. All rights reserved. |